Page last updated: 2024-10-16

aminolevulinic acid and Leishmaniasis, Visceral

aminolevulinic acid has been researched along with Leishmaniasis, Visceral in 1 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumari, S1
Samant, M1
Khare, P1
Misra, P1
Dutta, S1
Kolli, BK1
Sharma, S1
Chang, KP1
Dube, A1

Other Studies

1 other study available for aminolevulinic acid and Leishmaniasis, Visceral

ArticleYear
Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.
    European journal of immunology, 2009, Volume: 39, Issue:1

    Topics: Adoptive Transfer; Aminolevulinic Acid; Animals; Antibodies, Protozoan; Cricetinae; Cytokines; Cytot

2009